Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P28838
UPID:
AMPL_HUMAN
Alternative names:
Cysteinylglycine-S-conjugate dipeptidase; Leucine aminopeptidase 3; Leucyl aminopeptidase; Peptidase S; Proline aminopeptidase; Prolyl aminopeptidase
Alternative UPACC:
P28838; B3KMQ3; Q6IAM6; Q6P0L6; Q9UQE3
Background:
Cytosol aminopeptidase, known by alternative names such as Cysteinylglycine-S-conjugate dipeptidase and Leucine aminopeptidase 3, plays a crucial role in cellular processes. It is a cytosolic metallopeptidase that catalyzes the removal of N-terminal hydrophobic amino acids from peptides, requiring Zn(2+) ions for activity. Its function is modulated by cofactors, with Mn(2+) enhancing its specificity for Cys-Gly hydrolyzing activity. This enzyme is pivotal in glutathione metabolism and the degradation of glutathione S-conjugates, influencing cell redox status.
Therapeutic significance:
Understanding the role of Cytosol aminopeptidase could open doors to potential therapeutic strategies.